Phan Thi Phuong Dung, Dang Tuan Anh, Vu Binh Duong, Phan Dinh Chau
Hanoi University of Pharmacy, No. 13, Le Thanh Tong Str, Hoan Kiem District, Hanoi 11021, Vietnam.
National Institute of Medicinal Materials, No. 3B Quang Trung, Hoan Kiem District, Hanoi 11006, Vietnam.
ACS Omega. 2022 Feb 4;7(6):4787-4790. doi: 10.1021/acsomega.1c04652. eCollection 2022 Feb 15.
A simple and economical process for producing amantadine hydrochloride () on a 250 g scale, an antiviral and anti-Parkinson drug, has been developed. Several methods for the preparation of through intermediate -(1-adamantyl)-acetamide () in four or three steps were reported. These procedures started with adamantine () or 1-bromoadamantane (), acetonitrile, and sulfuric acid by using the Ritter-type reaction to obtain -(1-adamantyl)-acetamide, which was deacetylated to afford 1-amino-adamantane () and then the salt formed with anhydrous HCl gives with the overall yield of being 50-58%. In this article, a two-step procedure for the synthesis of from 1-bromadamantane () and formamide via -(1-adamantyl)-formamide () in two steps with an overall yield of 88% was reported. In this procedure, the preparation of from is a key step with a yield of 94%, followed by the hydrolysis of with an aq. solution of HCl to give in high yield (93%). The procedure was also carried out under optimal conditions established to reduce the use of toxic reagents or solvents and was carried out in one pot to make it more environmentally friendly. The procedure can be considered as more suitable for the large-scale production of . The structures of product and intermediate were confirmed by IR, MS, H NMR, C NMR.
已经开发出一种简单且经济的方法,可在250克规模上生产盐酸金刚烷胺(一种抗病毒和抗帕金森病药物)。报道了几种通过中间体1-(金刚烷-1-基)乙酰胺分四步或三步制备盐酸金刚烷胺的方法。这些方法以金刚烷或1-溴金刚烷、乙腈和硫酸为原料,利用 Ritter 型反应得到1-(金刚烷-1-基)乙酰胺,将其脱乙酰化得到1-氨基金刚烷,然后与无水HCl形成盐得到盐酸金刚烷胺,总收率为50-58%。在本文中,报道了一种从1-溴金刚烷和甲酰胺经1-(金刚烷-1-基)甲酰胺分两步合成盐酸金刚烷胺的方法,总收率为88%。在此方法中,由1-(金刚烷-1-基)甲酰胺制备1-氨基金刚烷是关键步骤,收率为94%,随后用盐酸水溶液水解1-氨基金刚烷以高产率(93%)得到盐酸金刚烷胺。该方法也是在为减少有毒试剂或溶剂使用而确定的最佳条件下进行的,并且是一锅法操作,使其更环保。该方法可被认为更适合大规模生产盐酸金刚烷胺。产物盐酸金刚烷胺和中间体1-(金刚烷-1-基)甲酰胺的结构通过红外光谱(IR)、质谱(MS)、核磁共振氢谱(1H NMR)、核磁共振碳谱(13C NMR)得以确证。